Geisinger South Wilkes-Barre
Wilkes Barre, Pennsylvania, United States
Medical center in Wilkes-Barre, Pennsylvania
25 Church St, Wilkes-Barre, PA 18765
About Geisinger South Wilkes-Barre
"At GSWB, a campus of Geisinger Wyoming Valley Medical Center, we offer quality and convenience. With a 24/7 Emergency Department, new medical and surgical suites, and the latest in laboratory and radiology services, the GSWB staff is ready to provide care for you."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
7
Alliance for Clinical Trials in Oncology
1
AppliedVR Inc.
1
Clinical Trials at Geisinger South Wilkes-Barre
During the past decade, Geisinger South Wilkes-Barre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 7 clinical trials were completed, i.e. on
average, 350% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Chemotherapy With or Without Bevacizumab in Treating Patients With Stage IB, Stage II, or Stage IIIA Non-small Cell Lung Cancer That Was Removed By Surgery
2007-06-01
2023-10-16
Active, not recruiting
1,501
Imatinib Mesylate With or Without Bevacizumab in Treating Patients With Metastatic or Unresectable Gastrointestinal Stromal Tumor
2008-04-01
2015-07-01
Terminated
12
Bevacizumab, Sorafenib Tosylate, and Temsirolimus in Treating Patients With Metastatic Kidney Cancer
2007-09-14
2017-03-21
Completed
361
Doxorubicin Hydrochloride, Cyclophosphamide, and Paclitaxel With or Without Bevacizumab in Treating Patients With Lymph Node-Positive or High-Risk, Lymph Node-Negative Breast Cancer
2007-11-02
Active, not recruiting
4,994
Octreotide Acetate and Recombinant Interferon Alfa-2b or Bevacizumab in Treating Patients With Metastatic or Locally Advanced, High-Risk Neuroendocrine Tumor
2007-12-01
Active, not recruiting
427
Fludarabine and Rituximab With or Without Lenalidomide or Cyclophosphamide in Treating Patients With Symptomatic Chronic Lymphocytic Leukemia
2008-01-15
Active, not recruiting
418
Lenalidomide and Dexamethasone With or Without Bortezomib in Treating Patients With Previously Untreated Multiple Myeloma
2008-04-01
Active, not recruiting
525
Axillary Reverse Mapping in Preventing Lymphedema in Patients With Breast Cancer Undergoing Axillary Lymph Node Dissection
2019-05-31
2024-01-01
Recruiting
516
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Geisinger South Wilkes-Barre"
#1 collaborator was "Cancer and Leukemia Group B" with 2 trials as a collaborator, "Eastern Cooperative Oncology Group" with 2 trials as a collaborator, "NCIC Clinical Trials Group" with 2 trials as a collaborator, "North Central Cancer Treatment Group" with 2 trials as a collaborator and "SWOG Cancer Research Network" with 2 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Geisinger South Wilkes-Barre
According to Clinical.Site data, the most researched conditions in "Geisinger South Wilkes-Barre" are
"Arthropathy of Knee" (1 trials), "Atypical Carcinoid Tumor" (1 trials), "Breast Adenocarcinoma" (1 trials), "Breast Cancer Stage I" (1 trials) and "Breast Cancer Stage II" (1 trials). Many other conditions were trialed in "Geisinger South Wilkes-Barre" in a lesser frequency.
Clinical Trials Intervention Types at Geisinger South Wilkes-Barre
Most popular intervention types in "Geisinger South Wilkes-Barre" are "Drug" (9 trials), "Other" (8 trials), "Biological" (6 trials), "Device" (1 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (7 trials), "Bevacizumab" (5 trials), "Cyclophosphamide" (2 trials), "Lenalidomide" (2 trials) and "Pharmacological Study" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Geisinger South Wilkes-Barre
The vast majority of trials in "Geisinger South Wilkes-Barre" are
8 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Geisinger South Wilkes-Barre
Currently, there are NaN active trials in "Geisinger South Wilkes-Barre".
undefined are not yet recruiting,
1 are recruiting,
6 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 1 completed trials in Geisinger South Wilkes-Barre,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Geisinger South Wilkes-Barre, 0 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 1 trials that are defined as “Not Applicable".